What is SXTP's health score?

60 DEGREES PHARMACEUTICALS, INC. (SXTP) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SXTP's estimated fair value?

Based on our 5-year discounted cash flow model, 60 DEGREES PHARMACEUTICALS, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is SXTP undervalued or overvalued?

Our model currently rates SXTP as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Healthcare Inconclusive inconclusive weak

$1.47

Updated: 2026-07-14

TradeApes Score

Financial Strength

35 Weak

Operating Trend

45 Mixed

Relative Value

60 Healthy

Capital Allocation

10 Stressed

Risk Management

35 Weak

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Industry Related Stocks

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH) AbbVie Inc. (ABBV) AbCellera Biologics Inc. (ABCL)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.